Themis Medicare Profit & Loss Annual

BSE: 530199 | NSE: THEMISMED | ISIN: INE083B01024 | Sector: Major Drugs

296.60 +7.10 (2.45%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	381.76	354.32	394.61	230.67
Total Revenue	381.76	354.32	394.61	230.67
Costof Revenue Total	136.71	134.93	168.49	87.20
Gross Profit	245.05	219.39	226.13	143.47
Selling/ General/ Admin Expenses Total	82.41	131.54	111.63	79.82
Depreciation/ Amortization	12.25	10.49	9.48	8.55
Other Operating Expenses Total	111.13	20.40	18.86	14.16
Total Operating Expense	342.50	297.37	308.46	189.72
Operating Income	39.26	56.96	86.16	40.95
Interest Inc( Exp) Net- Non- Op Total	94.29	136.60	100.80	14.49
Other Net	4.76	1.90	-0.97	-1.06
Net Income Before Taxes	53.44	72.51	95.26	41.33
Provisionfor Income Taxes	9.92	15.61	22.38	5.63
Net Income After Taxes	43.52	56.90	72.88	35.70
Minority Interest	0.00	0.00	0.00	0.00
Net Income Before Extra Items	43.52	56.90	72.88	35.70
Net Income	43.52	56.90	72.88	35.70
Income Availableto Com Excl Extra Ord	43.52	56.90	72.88	35.70
Income Availableto Com Incl Extra Ord	43.52	56.90	72.88	35.70
Diluted Net Income	43.52	56.90	72.88	35.70
Diluted Weighted Average Shares	9.22	9.22	9.22	9.19
Diluted EPS Excluding Extra Ord Items	4.72	6.17	7.91	3.88
DPS- Common Stock Primary Issue	0.50	0.50	0.50	0.43
Diluted Normalized EPS	4.72	6.17	7.91	3.88